Status:
COMPLETED
Long-term Study of Efficacy/Safety of Adapalene/Benzoyl Peroxide Topical Gel in Acne Vulgaris Subjects
Lead Sponsor:
Galderma R&D
Conditions:
Acne Vulgaris
Eligibility:
All Genders
12+ years
Phase:
PHASE3
Brief Summary
This was a multi-center, open-label, non-comparative study that evaluated the long-term safety and efficacy profile of Adapalene/Benzoyl Peroxide Gel. Subjects were evaluated at Baseline, Weeks 1 and...
Eligibility Criteria
Inclusion
- A clinical diagnosis of acne vulgaris with facial involvement.
- A minimum of 20 but not more than 50 Inflammatory lesions.
- A minimum of 30 but not more than 100 Noninflammatory lesions.
Exclusion
- Subjects with presence of nodules or cysts.
- Acne conglobate, acne fulminans, secondary acne, or severe acne.
- Underlying diseases that required the use of interfering topical or systemic therapy.
- Use of prohibited medications prior to the study unless appropriate washout period was documented.
Key Trial Info
Start Date :
February 17 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 23 2005
Estimated Enrollment :
452 Patients enrolled
Trial Details
Trial ID
NCT00446043
Start Date
February 17 2004
End Date
May 23 2005
Last Update
July 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Phoebe Rich, MD
Portland, Oregon, United States, 97210